Mantec, Lenie Joy L.
HRN: 14-02-81 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/18/2022
CEFUROXIME 500MG (TAB)
12/18/2022
12/25/2022
PO
500mg
Q12
S/P NSVD; T/c UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes